Nienke Jabben1, Baer Arts, Jim van Os, Lydia Krabbendam. 1. Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands.
Abstract
OBJECTIVE: Neurocognitive functioning may represent an indicator of genetic risk and poor outcome in both schizophrenia and bipolar disorder. In this study, shared and nonshared characteristics in the cognitive domain in both disorders were analyzed to determine to what degree neurocognitive functioning may represent a predictor of the familial vulnerability and poor functioning that schizophrenia spectrum disorders and bipolar disorder share. METHOD: Neurocognition, psychopathology, and psychosocial functioning were assessed in samples of patients with a schizophrenia spectrum disorder (n = 345) and bipolar disorder (n = 76) meeting DSM-IV criteria, first-degree relatives of both patient groups (n = 331 and n = 37, respectively), and healthy controls (n = 260 and n = 61, respectively). Multiple regression models were used to investigate the effect of group status on neurocognition and to explore associations between cognition, symptoms, and psychosocial functioning in the 2 groups. The schizophrenia spectrum study sample was recruited between September 2004 and January 2008, and the bipolar study sample was recruited between June 2004 and July 2007. RESULTS: Cognitive deficits were more severe and more generalized in patients with a schizophrenia spectrum disorder compared to patients with bipolar disorder; cognitive alterations were present in relatives of patients with schizophrenia spectrum disorders but not in relatives of bipolar patients. The association between neurocognitive dysfunction and psychosocial functioning was more generalized in schizophrenia spectrum disorders than in bipolar disorder; for both disorders, associations were only partly mediated by symptoms. CONCLUSIONS: The evidence for cognitive dysfunction as a marker of familial vulnerability is stronger for schizophrenia than for bipolar disorder. Although the presence of multiple cognitive deficits is shared by the 2 groups, the severity of cognitive deficits and its consequences appear to partly differ between schizophrenia and bipolar disorder, which is in line with a model that implies the specific presence of a neurodevelopmental impairment in the former but not in the latter. 2010 Physicians Postgraduate Press, Inc.
OBJECTIVE: Neurocognitive functioning may represent an indicator of genetic risk and poor outcome in both schizophrenia and bipolar disorder. In this study, shared and nonshared characteristics in the cognitive domain in both disorders were analyzed to determine to what degree neurocognitive functioning may represent a predictor of the familial vulnerability and poor functioning that schizophrenia spectrum disorders and bipolar disorder share. METHOD: Neurocognition, psychopathology, and psychosocial functioning were assessed in samples of patients with a schizophrenia spectrum disorder (n = 345) and bipolar disorder (n = 76) meeting DSM-IV criteria, first-degree relatives of both patient groups (n = 331 and n = 37, respectively), and healthy controls (n = 260 and n = 61, respectively). Multiple regression models were used to investigate the effect of group status on neurocognition and to explore associations between cognition, symptoms, and psychosocial functioning in the 2 groups. The schizophrenia spectrum study sample was recruited between September 2004 and January 2008, and the bipolar study sample was recruited between June 2004 and July 2007. RESULTS:Cognitive deficits were more severe and more generalized in patients with a schizophrenia spectrum disorder compared to patients with bipolar disorder; cognitive alterations were present in relatives of patients with schizophrenia spectrum disorders but not in relatives of bipolarpatients. The association between neurocognitive dysfunction and psychosocial functioning was more generalized in schizophrenia spectrum disorders than in bipolar disorder; for both disorders, associations were only partly mediated by symptoms. CONCLUSIONS: The evidence for cognitive dysfunction as a marker of familial vulnerability is stronger for schizophrenia than for bipolar disorder. Although the presence of multiple cognitive deficits is shared by the 2 groups, the severity of cognitive deficits and its consequences appear to partly differ between schizophrenia and bipolar disorder, which is in line with a model that implies the specific presence of a neurodevelopmental impairment in the former but not in the latter. 2010 Physicians Postgraduate Press, Inc.
Authors: Shashwath A Meda; Adrienne Gill; Michael C Stevens; Raymond P Lorenzoni; David C Glahn; Vince D Calhoun; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Gunvant Thaker; Godfrey D Pearlson Journal: Biol Psychiatry Date: 2012-03-07 Impact factor: 13.382
Authors: Unn K Haukvik; Lars M Rimol; J Cooper Roddey; Cecilie B Hartberg; Elisabeth H Lange; Anja Vaskinn; Ingrid Melle; Ole A Andreassen; Anders Dale; Ingrid Agartz Journal: Schizophr Bull Date: 2013-02-18 Impact factor: 9.306
Authors: Susan S Kuo; Laura Almasy; Ruben C Gur; Konasale Prasad; David R Roalf; Raquel E Gur; Vishwajit L Nimgaonkar; Michael F Pogue-Geile Journal: J Abnorm Psychol Date: 2018-02
Authors: Colin A Depp; Brent T Mausbach; Alexandrea L Harmell; Gauri N Savla; Christopher R Bowie; Philip D Harvey; Thomas L Patterson Journal: Bipolar Disord Date: 2012-05 Impact factor: 6.744
Authors: Julia W Y Kam; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick; Colleen A Brenner Journal: J Affect Disord Date: 2011-07-23 Impact factor: 4.839
Authors: Samira Menegas; Camila L Ferreira; José Henrique Cararo; Fernanda F Gava; Gustavo C Dal-Pont; Maria L Gomes; Jotele F Agostini; Patrícia Fernanda Schuck; Giselli Scaini; Monica L Andersen; João Quevedo; Samira S Valvassori Journal: Metab Brain Dis Date: 2019-03-27 Impact factor: 3.584
Authors: Silvia Scala; Andrea Pousada; William S Stone; Heidi W Thermenos; Theo C Manschreck; Ming T Tsuang; Stephen V Faraone; Larry J Seidman Journal: Schizophr Res Date: 2013-01-09 Impact factor: 4.939
Authors: Ezra Wegbreit; Grace K Cushman; Alexandra B Weissman; Erin Bojanek; Kerri L Kim; Ellen Leibenluft; Daniel P Dickstein Journal: J Affect Disord Date: 2016-05-26 Impact factor: 4.839
Authors: Frank Bellivier; Pierre Alexis Geoffroy; Jan Scott; Franck Schurhoff; Marion Leboyer; Bruno Etain Journal: Front Biosci (Elite Ed) Date: 2013-06-01